Andrew Arnold - Concepedia

Author

Andrew Arnold

Also Known As

A ARNOLD, A Arnold, A M Arnold, A. Arnold, A. M. Arnold, A.M Arnold, A.M. Arnold, ANDREW ARNOLD, Aaron Arnold, Alan Arnold

329

Publications

26.8K

Citations

H-Index

174

Concepts

All Affiliations

Massachusetts General Hospital University of Connecticut Harvard University UConn Health National Institutes of Health

About

Andrew Arnold is an author at Massachusetts General Hospital specializing in medicine, pathology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	44	79	13K
2	Health Sciences	14	17	1.9K
3	Engineering	5	5	139
4	Language Studies	4	4	99
5	Education	2	2	59

Andrew Arnold

171

Publications

23.5K

Citations

H-Index

Page 1

	Year	Citations
A novel cyclin encoded by a bcl1-linked candidate oncogene Toru Motokura, Theodora Bloom, Hyung Goo Kim, Nature Novel CyclinOncogenic AgentMolecular BiologyMolecular GeneticsCell Cycle	1991	1.3K
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins Philip W. Hinds, Sibylle Mittnacht, Vjekoslav Dulić, Cell Signal TransductionCell RegulationMolecular RegulationEctopic ExpressionCell Proliferation	1992	1K
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice Timothy C. Wang, Robert D. Cardiff, Lawrence Zukerberg, Nature Breast OncologyMammary GlandBreast CancerMedicineCell Biology	1994	974
The Effect of Group Psychosocial Support on Survival in Metastatic Breast Cancer Pamela J. Goodwin, Molyn Leszcz, Marguerite Ennis, New England Journal of Medicine	2001	891
Transforming p21 Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions Chris Albanese, Janet Johnson, Genichi Watanabe, Journal of Biological Chemistry	1995	804
Physical interaction of the retinoblastoma protein with human D cyclins Steven F. Dowdy, Philip W. Hinds, Kenway Louie, Cell Retinoblastoma ProteinMolecular BiologyCytoskeletonMedicineCell Biology	1993	761
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. Nevin Murray, P. Coy, Joseph L. Pater, Journal of Clinical Oncology	1993	725
Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. E Rapp, Joseph L. Pater, Andrew R. Willan, Journal of Clinical Oncology OncologyCombination ChemotherapyCancer ManagementMetronomic TherapyClinical Trials	1988	699
Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group. Mark N. Levine, V. Bramwell, Kathleen I. Pritchard, Journal of Clinical Oncology	1998	622
Immunoglobulin-Gene Rearrangements as Unique Clonal Markers in Human Lymphoid Neoplasms Andrew Arnold, Jeffrey Cossman, Ajay Bakhshi, New England Journal of Medicine GeneticsImmunologyPathologyImmunophenotypingImmunoglobulin-gene Rearrangements	1983	610

Page 1